These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ocular surface cytokine profile in chronic Stevens-Johnson syndrome and its response to mucous membrane grafting for lid margin keratinisation. Gurumurthy S; Iyer G; Srinivasan B; Agarwal S; Angayarkanni N Br J Ophthalmol; 2018 Feb; 102(2):169-176. PubMed ID: 28689166 [TBL] [Abstract][Full Text] [Related]
3. Multistep Grading System for Evaluation of Chronic Ocular Sequelae in Patients With Stevens-Johnson Syndrome. Sharma N; Venugopal R; Maharana PK; Chaniyara M; Agarwal T; Pushker N; Pandey RM; Sangwan S; Sen S; Kashyap S; Sharma A; Khanna N; Vajpayee RB Am J Ophthalmol; 2019 Jul; 203():69-77. PubMed ID: 30731084 [TBL] [Abstract][Full Text] [Related]
4. Predictive Factors Associated With Acute Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Sotozono C; Ueta M; Nakatani E; Kitami A; Watanabe H; Sueki H; Iijima M; Aihara M; Ikezawa Z; Aihara Y; Kano Y; Shiohara T; Tohyama M; Shirakata Y; Kaneda H; Fukushima M; Kinoshita S; Hashimoto K; Am J Ophthalmol; 2015 Aug; 160(2):228-237.e2. PubMed ID: 25979679 [TBL] [Abstract][Full Text] [Related]
5. Regulation of gene expression by miRNA-455-3p, upregulated in the conjunctival epithelium of patients with Stevens-Johnson syndrome in the chronic stage. Ueta M; Nishigaki H; Sotozono C; Yokoi N; Mizushima K; Naito Y; Kinoshita S Sci Rep; 2020 Oct; 10(1):17239. PubMed ID: 33057072 [TBL] [Abstract][Full Text] [Related]
6. Ocular manifestations in patients with Stevens-Johnson syndrome in Malawi-review of the literature illustrated by clinical cases. Schulze Schwering M; Kayange P; Rothe C Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2343-2348. PubMed ID: 31352606 [TBL] [Abstract][Full Text] [Related]
7. Association of human antigen class I genes with cold medicine-related Stevens-Johnson syndrome with severe ocular complications in a Korean population. Jun I; Rim JH; Kim MK; Yoon KC; Joo CK; Kinoshita S; Seo KY; Ueta M Br J Ophthalmol; 2019 Apr; 103(4):573-576. PubMed ID: 30705045 [TBL] [Abstract][Full Text] [Related]
8. A cross-sectional comparative study on chronic ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series. Chow LLW; Ng ALK; Chow SSW; Choy BNK; Shih KC; Wong IYH; Chan JCY; Lai JSM Int Ophthalmol; 2018 Jun; 38(3):1155-1160. PubMed ID: 28547534 [TBL] [Abstract][Full Text] [Related]
9. Association between HLA-B*44:03-HLA-C*07:01 haplotype and cold medicine-related Stevens-Johnson syndrome with severe ocular complications in Thailand. Jongkhajornpong P; Lekhanont K; Pisuchpen P; Chantaren P; Puangsricharern V; Prabhasawat P; Suphapeetiporn K; Kinoshita S; Ueta M Br J Ophthalmol; 2018 Sep; 102(9):1303-1307. PubMed ID: 29706602 [TBL] [Abstract][Full Text] [Related]
10. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. De Rojas MV; Dart JK; Saw VP Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145 [TBL] [Abstract][Full Text] [Related]
11. The relationship between preoperative clinical scores and immunohistological evaluation of surgically resected tissues in chronic severe ocular surface diseases. Tanioka H; Kawasaki S; Sotozono C; Nakamura T; Inatomi T; Kinoshita S Jpn J Ophthalmol; 2010 Jan; 54(1):66-73. PubMed ID: 20151279 [TBL] [Abstract][Full Text] [Related]
12. Association of Human Leukocyte Antigen Class 1 genes with Stevens Johnson Syndrome with severe ocular complications in an Indian population. Kannabiran C; Ueta M; Sangwan V; Rathi V; Basu S; Tokunaga K; Kinoshita S Sci Rep; 2017 Nov; 7(1):15960. PubMed ID: 29162886 [TBL] [Abstract][Full Text] [Related]
13. Expression of prostaglandin E Mieno H; Ueta M; Yamada K; Yamanaka Y; Nakayama T; Watanabe A; Kinoshita S; Sotozono C Br J Ophthalmol; 2020 Jul; 104(7):1022-1027. PubMed ID: 31000507 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the ocular microbiome between chronic Stevens-Johnson syndrome patients and healthy subjects. Kittipibul T; Puangsricharern V; Chatsuwan T Sci Rep; 2020 Mar; 10(1):4353. PubMed ID: 32152391 [TBL] [Abstract][Full Text] [Related]
15. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. Sotozono C; Ang LP; Koizumi N; Higashihara H; Ueta M; Inatomi T; Yokoi N; Kaido M; Dogru M; Shimazaki J; Tsubota K; Yamada M; Kinoshita S Ophthalmology; 2007 Jul; 114(7):1294-302. PubMed ID: 17475335 [TBL] [Abstract][Full Text] [Related]
16. Molecular and metabolic retinoid pathways in the human ocular surface. Nezzar H; Chiambaretta F; Marceau G; Blanchon L; Faye B; Dechelotte P; Rigal D; Sapin V Mol Vis; 2007 Sep; 13():1641-50. PubMed ID: 17893666 [TBL] [Abstract][Full Text] [Related]
17. [Conjunctival Fas-FasL expression in chronic Stevens-Johnson syndrome]. Chen S; Jiang Y; Wang Z; Li Y Zhonghua Yan Ke Za Zhi; 2014 Sep; 50(9):691-4. PubMed ID: 25533561 [TBL] [Abstract][Full Text] [Related]
18. Biological activity of N-(4-hydroxyphenyl) retinamide-O-glucuronide in corneal and conjunctival cells of rabbits and humans. Ubels JL; Dennis MH; Mitchell JH; Wiley LA; Curley RW Curr Eye Res; 1995 Dec; 14(12):1115-24. PubMed ID: 8974841 [TBL] [Abstract][Full Text] [Related]
19. [Ocular complication in children with Stevens-Johnson syndrome]. Gotz-Wieckowska A; Bernardczyk-Meller J; Rakowicz P Klin Oczna; 2003; 105(6):414-6. PubMed ID: 15049268 [TBL] [Abstract][Full Text] [Related]
20. HLA typing in patients with ocular manifestations of Stevens-Johnson syndrome. Power WJ; Saidman SL; Zhang DS; Vamvakas EC; Merayo-Lloves JM; Kaufman AH; Foster CS Ophthalmology; 1996 Sep; 103(9):1406-9. PubMed ID: 8841298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]